Compact and very high dose-rate plasma focus radiation sources for medical applications

被引:6
作者
Isolan, Lorenzo [1 ,2 ]
Laghi, Davide [1 ]
Zironi, Isabella [2 ,3 ]
Cremonesi, Marta [4 ]
Garibaldi, Cristina [4 ]
Buontempo, Francesca [5 ]
Sumini, Marco [1 ,2 ,6 ]
机构
[1] Univ Bologna, Ind Engn Dept, Bologna, Italy
[2] Ist Nazl Fis Nucl INFN, Natl Inst Nucl Phys, Bologna, Italy
[3] Univ Bologna, Phys & Astron Dept Augusto Righi DIFA, Bologna, Italy
[4] European Inst Oncol IRCCS, Unit Radiat Res, IEO, Milan, Italy
[5] Biotechnol Profess, Bologna, Italy
[6] Univ Bologna, Ind Engn Dept, Montecuccolino Lab, Via Colli 16, I-40136 Bologna, Italy
关键词
MCNP; MCDS; Ultra -high dose -rate; Sensitivity analysis; RBE; RADIOTHERAPY; DEVICE; MECHANISM; FUSION; MODELS; PULSES; CELLS; ION;
D O I
10.1016/j.radphyschem.2022.110296
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A Dense Plasma Focus (DPF) is a pulsed device able to produce a hot and dense short-lived plasma that could become a fast radiation source for diagnostic applications, external radiotherapy, or intra-operative radiation therapy. The plasma confinement phase, identified as "pinch", lasts few tens of nanoseconds, during which thermonuclear temperatures and densities could be reached. When the DPF vacuum chamber is filled with gases such as nitrogen, the only significant output are self-collimated charged particle beams (electrons and ions in opposite direction). Using that electron beam, it is possible to devise an ultra-high dose-rate source, with ap-plications for direct irradiation of a tumor bed or for photon conversion after the interaction with a suitable target. The ultra-high dose rate could have potential benefits in mitigating the intrinsic or acquired malignant cell radio-resistance, which can be considered the main obstacle to the long-term survival of a patient, also sparing healthy tissues. This is due as the faster the dose deposition, the more relevant is the radiobiological efficacy (as the tumor cells do not have the time to activate the sub-lethal damage repair mechanisms responsible of the radio-resistance). Due to the novelty of the fast source, the usual models cannot easily describe the bio-logical outcomes, therefore new numerical approaches are needed for predicting the RBE outlined in these regimens.A parametric investigation through the Monte Carlo Damage Simulation Software (MCDS), coupled with the Monte Carlo N-Particle (MCNP) code, has been performed for supporting the experimental results previously obtained by irradiating melanoma cell lines with the Plasma Focus Device for Medical Applications #3 (PFMA-3) as UHDR source and a conventional XRT as standard of comparison.The experimental data were benchmarked with MCNP-MCDS, properly fitting the XRT curves. The validation of the MCDS-MCNP coupling was performed by comparing literature data for conventional XRT, with less than 4% of differences. Next, the experimentally evaluated RBE highlighted that for high doses the RBE calculated on the basis of the surviving fraction (RBE(SF)), is the same of the one from double strand break damages (RBE (DSB)), making coherent the application of the Repair Misrepair Fixation theory (RMF) and providing a basis for a reliable comparison between the two devices. The DPF irradiation outcome has been numerically investigated correlating the experimental experiences with a wide range of code parameter variations to find numerical conditions able to reproduce the data. A recipe based on a combination of more than one SF curves to fit the clonogenic assay in UHDR regimen has also been proposed.The results suggested that the UHDR regimen obtained from the DPF source could change the environmental conditions (e.g., oxygen concentration) while cumulating the dose. This implies that a combination of data and MCDS-MCNP analysis could be applied as a strategy for quantifying biological effects.
引用
收藏
页数:9
相关论文
共 63 条
  • [1] Oxygen depletion in FLASH ultra-high-dose-rate radiotherapy: A molecular dynamics simulation
    Abolfath, Ramin
    Grosshans, David
    Mohan, Radhe
    [J]. MEDICAL PHYSICS, 2020, 47 (12) : 6551 - 6561
  • [2] Aya-Bonilla CA, 2017, ONCOTARGET, V8, P67355, DOI 10.18632/oncotarget.18641
  • [3] GENOMIC INSTABILITY IN CANCER Strategies to improve radiotherapy with targeted drugs
    Begg, Adrian C.
    Stewart, Fiona A.
    Vens, Conchita
    [J]. NATURE REVIEWS CANCER, 2011, 11 (04) : 239 - 253
  • [4] Variation of 4 MV X-ray dose rate strongly impacts biological response both in vitro and in vivo
    Ben Kacem, M.
    Benadjaoud, M. A.
    Dos Santos, M.
    Soysouvanh, F.
    Buard, V.
    Tarlet, G.
    Le Guen, B.
    Francois, A.
    Guipaud, O.
    Milliat, F.
    Paget, V.
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [5] Development of the dense plasma focus for short-pulse applications
    Bennett, N.
    Blasco, M.
    Breeding, K.
    Constantino, D.
    DeYoung, A.
    DiPuccio, V.
    Friedman, J.
    Gall, B.
    Gardner, S.
    Gatling, J.
    Hagen, E. C.
    Luttman, A.
    Meehan, B. T.
    Misch, M.
    Molnar, S.
    Morgan, G.
    O'Brien, R.
    Robbins, L.
    Rundberg, R.
    Sipe, N.
    Welch, D. R.
    Yuan, V.
    [J]. PHYSICS OF PLASMAS, 2017, 24 (01)
  • [6] Recent advances in radiotherapy
    Bhide, S. A.
    Nutting, C. M.
    [J]. BMC MEDICINE, 2010, 8
  • [7] Treatment of a first patient with FLASH-radiotherapy
    Bourhis, Jean
    Sozzi, Wendy Jeanneret
    Jorge, Patrik Goncalves
    Gaide, Olivier
    Bailat, Claude
    Duclos, Frederic
    Patin, David
    Ozsahin, Mahmut
    Bochud, Francois
    Germond, Jean-Francois
    Moeckli, Raphael
    Vozenin, Marie-Catherine
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 139 : 18 - 22
  • [8] CONDITIONS FOR THE EQUIVALENCE OF CONTINUOUS TO PULSED LOW-DOSE RATE BRACHYTHERAPY
    BRENNER, DJ
    HALL, EJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (01): : 181 - 190
  • [9] Brown J.M., 2014, COMPREHENSIVE BIOMED, P97, DOI [10.1016/B978-0-444-53632-7.00806-6, DOI 10.1016/B978-0-444-53632-7.00806-6]
  • [10] Characterization of biological effects in radiotherapy applications of ultra-high dose rate pulses from a plasma focus device
    Buontempo, F.
    Isolan, L.
    Zironi, I.
    Castellani, G.
    Nano, R.
    Pasi, F.
    Tartari, A.
    Mostacci, D.
    Sumini, M.
    Martelli, A. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S159 - S159